Siren LLC’s Alto Neuroscience ANRO Stock Holding History

Siren LLC’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-391,406	Closed	-$4.48M	–	129
2024 Q3	$4.48M	Buy	+391,406	New	+$4.79M	0.22%	68

Other funds holding ANRO

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Siren LLC's ANRO Position: Q4 2024 in Review

Siren LLC sold out of Alto Neuroscience (ANRO) in Q4 2024, closing a stake of 391,406 shares — an estimated $4.48M sold.

Siren LLC first reported a position in ANRO in Q3 2024 and held it in 1 quarter. The position peaked at $4.48M in Q3 2024. 77 funds tracked by Wall St. Rank hold ANRO as of Q4 2024.

Siren LLC reported no remaining Alto Neuroscience position as of Q4 2024 after selling out during the quarter.
Siren LLC sold 391,406 Alto Neuroscience shares in Q4 2024, an estimated $4.48M.
Siren LLC first reported a position in Alto Neuroscience in Q3 2024 and held it in 1 quarter.
Siren LLC's Alto Neuroscience position peaked at $4.48M in Q3 2024.
77 funds tracked by Wall St. Rank held Alto Neuroscience as of Q4 2024.

Based on Siren LLC's 13F filing for Q4 2024, filed 14 Feb 2025.